Sunday, July 21, 2024 2:58:40 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent TRVI News
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 05/07/2026 10:23:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 08:09:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:07:38 PM
- Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 05/05/2026 08:05:00 PM
- Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference • GlobeNewswire Inc. • 04/30/2026 08:05:00 PM
- Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026 • GlobeNewswire Inc. • 04/28/2026 08:05:00 PM
- Trevi Therapeutics to Participate in Upcoming May Events • GlobeNewswire Inc. • 04/23/2026 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/21/2026 08:00:16 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2026 08:00:11 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/21/2026 08:00:03 PM
- Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares • GlobeNewswire Inc. • 04/20/2026 08:05:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/17/2026 08:17:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 12:06:31 PM
- Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock • GlobeNewswire Inc. • 04/17/2026 02:42:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/16/2026 08:16:24 PM
- Trevi Therapeutics Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 04/16/2026 08:08:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/10/2026 08:32:57 PM
- Trevi Therapeutics to Participate in Upcoming Events • GlobeNewswire Inc. • 04/01/2026 11:30:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/17/2026 08:08:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 08:07:16 PM
- Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/17/2026 08:05:00 PM
- Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026 • GlobeNewswire Inc. • 03/10/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 08:35:04 PM
- Trevi Therapeutics Announces Completion of End-of-Phase 2 Meeting with the FDA, Gaining Alignment for Its Development Program for Idiopathic Pulmonary Fibrosis-Related Chronic Cough • GlobeNewswire Inc. • 03/09/2026 11:30:00 AM
- Trevi Therapeutics to Participate in Upcoming March Conferences • GlobeNewswire Inc. • 03/02/2026 12:30:00 PM

